Document Mentions (3 shared documents)

EFTA00135796

2 mentions1 same-page

Page ?Same page

itors scheduled. This Town: • Brookings online discussion on the defense industrial base - 'The defense industrial base and the future of warfare' Brookings Institution Foreign Policy program online event exploring the future of the defense industrial base and challenges facing policymakers and the industry. Speake

patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey EFTA00135821 said the drug has approvals or authorizations in around 50 countries. The New Ynrk TIMP4 (10/22, Levenson, 18.61M) reports the FDA's

EFTA00136939

2 mentions1 same-page

Page ?Same page

itors scheduled. This Town: * Brookings online discussion on the defense industrial base — `The defense industrial base and the future of warfare' Brookings Institution Foreign Policy program online event exploring the future of the defense industrial base and challenges facing policymakers and the industry. Speaker

ws/health/2020/10/22/fda-approves-remdesivir-covid-19- hospital-patients/3733648001/> (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. The New York Times <https://www.nytimes.com/2020/10/22/us/remdesivir-fda-appr

EFTA00148445

2 mentions1 same-page

Page ?Same page

patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. EFTA00148471 The New York Times (10/22, Levenson, 18.61M) reports the FDA's